Novel Coronavirus (COVID-19) Resources and Special Communications
Below are links to AHA resources developed in response to novel coronavirus (COVID-19). For all coronavirus resources and news updates, visit our COVID-19 page.
Latest
This week, the State Department instructed U.S. embassies and consulates to prioritize “as emergencies on a case-by-case basis the immigrant visa cases of certain health care
In Becker’s Hospital Review, chief nursing officers (CNOs) this month described how they are coping with the unprecedented workforce shortage resulting from the pandemic.
The Health Resources and Services Administration (HRSA) released a fact sheet outlining the various personnel-related costs that can be covered by Provider Relief Fund (PRF) dollars.
We’re trying to reach hospital and health system employees that have yet to be vaccinated. Using your phone, we need you to record a short message about why it’s important that people in heath settings get vaccinated.
Though the health care industry is continuing to tackle the COVID-19 pandemic, many industry leaders are also looking to build a more resilient supply chain by asking, “What could we have done diff
Hospitals have fewer nurses to draw on as the delta variant of COVID-19 fills hospital beds once again. Early retirements and career shifts to outpatient settings have thinned
The COVID-19 pandemic “has unlocked new momentum in the delivery of care to patients, with notable advancements powered by nurses,” wrote Robyn Begley
The AHA today released new public service announcements (PSAs) and related digital content encouraging vaccination against COVID-19 by still-unvaccinated health care workers and members of the publ
Hospitals and health systems remain on the front lines of the COVID-19 pandemic and continue to play an important role in efforts to
The Food and Drug Administration today granted full approval for the Pfizer-BioNTech COVID-19 vaccine for individuals age 16 and over. The vaccine, which will now be marketed as Comirnaty, is the first COVID-19 vaccine to go beyond emergency use status in the United States.
The full approval of the Pfizer-BioNTech COVID-19 vaccine by the U.S. Food and Drug Administration (FDA) – the result of many months of work, robust data evaluation, and a thorough, comprehensive review process that has already protected more than one hundred million Americans from severe COVID-19 complications – is a major step forward in the worldwide effort to end this pandemic.
AHA’s comments to OSHA on the agency’s COVID-19 Emergency Temporary Standard.
COVID-19 Workplace Commons is a worldwide community dedicated to enabling the sharing of information on workplace practices regarding the coronavirus pandemic.
The COVID-19 pandemic “has unlocked new momentum in the delivery of care to patients, with notable advancements powered by nurses,” write Robyn Begley, AONL CEO
An analysis in the August issue of Nurse Leader outlines the effects of the pandemic on nurse sensitive indicators (NSIs) as described by chief nursing officers from across
Project Firstline is seeking U.S. health care personnel involved in overseeing students and/or teaching infection control to participate in a focus group and share their
As health care emerges from the COVID-19 pandemic, supply chain resiliency is a priority.
AHA model comments on OSHA’s COVID-19 Emergency Temporary Standard.